The RBM Partnership to End Malaria, through its Country and Regional Support Partner Committee (CRSPC) and in collaboration with its partners, will organise a face-to-face annual sub-regional meeting with National Malaria Programmes and partners for Eastern and Southern African countries in Lusaka, Zambia from 16-19 September 2024.
The sun rose, the birds were startled
Where are the sick children?
Fevers running high
Pencils set aside
New research from Oxford Economics Africa, commissioned by RBM partner Malaria No More UK, reveals that getting back on track for the Sustainable Development Goal target on malaria would significantly bolster African economies and increase global trade.
Achieving the target of reducing malaria by 90% from 2015 levels by 2030 could increase African GDP by $126.9 billion cumulatively between 2023 and 2030, averaging an annual boost of nearly $16 billion, larger than Niger’s entire economy today.
On 20 June 2024, a high-level event co-hosted in Paris by the Government of France, the African Union and Gavi, the Vaccine Alliance, along with the support of Team Europe, will launch the African Vaccine Manufacturing Accelerator (AVMA), an initiative that will provide financial incentives to help vaccine manufacturers in Africa scale up production and become sustainable on a long-term basis.
The event will also make the case for donors to invest in a new era of immunisation with the launch of Gavi’s investment opportunity for 2026–2030.